SK's Chey Tae-won visits U.S. affiliates to check up on business

SK Group Chairman Chey Tae-won visited SK affiliates in the U.S. to hear about progress and planning in the face of changing business environments.

SK Group Chairman Chey Tae-won, third from left, takes a selfie with Absolics staff at its headquarters in Georgia on July 3. [SK GROUP]

SK Group Chairman Chey Tae-won paid a visit to the U.S. offices of its affiliates to check up on local business.

Chey visited SK Life Science office in New Jersey on July 2 to get reports on direct sales of its anti-seizure medication Cenobamate in the country, of which prescriptions recently exceeded 100,000.

The chairman asked local staff to monitor the effect of the U.S. Biosecure Act concerning national security and come up with corresponding measures.

His next stop was the glass substrate manufacturing facilities of Absolics, a subsidiary of SKC located in Georgia.

Glass substrate is emerging as "game changer" material in chip packaging, especially in the AI era in which the amount of data that needs to be processed increases exponentially.

SK's Chey is known to have promoted the emerging material to Big Tech CEOs he met with earlier.

The chairman embarked on his U.S. business trip last month, meeting with big shots of Silicon Valley including OpenAI CEO Sam Altman and Microsoft CEO Satya Nadella.

"On the back of the results of Chey's U.S. business trip, SK companies like SK hynix and SK Telecom will conduct follow-up discussions with Big Tech partners for fortification of SK's AI ecosystem," SK Group said in a release Sunday.

BY JIN EUN-SOO [jin.eunsoo@joongang.co.kr]